BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 1960560)

  • 1. Radiotherapy for Advanced Hodgkin Lymphoma with Initial Bulk: A Combined Analysis of Two Randomized Trials.
    Hughes RT; Razavian NB; Shenker RF; Kelsey CR; Smith S; D'Agostino RB; Winkfield KM
    Adv Radiat Oncol; 2024 May; 9(5):101450. PubMed ID: 38550369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose palliative radiotherapy for malignant peripheral T-cell lymphoma masked by cellulitis and osteomyelitis: a case report.
    Alayed Y
    BJR Case Rep; 2024 Jan; 10(1):uaad010. PubMed ID: 38352262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Radiation Therapy in Mortality among Adolescents and Young Adults with Lymphoma: Differences According to Cause of Death.
    Yin X; You L; Hu X
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wang S; Jia M; Han J; Zhang R; Huang K; Li P; Li Q; Qiao Y; Song Q; Fu Z
    Cancer Biol Ther; 2020 Sep; 21(9):832-840. PubMed ID: 32835569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era.
    Lapuz C; Enjeti AK; O'Brien PC; Capp AL; Holliday EG; Gupta SA
    Blood Lymphat Cancer; 2018; 8():13-20. PubMed ID: 31360090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
    Gordon LI; Hong F; Fisher RI; Bartlett NL; Connors JM; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Gospodarowicz M; Advani R; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ
    J Clin Oncol; 2013 Feb; 31(6):684-91. PubMed ID: 23182987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does radiotherapy still have a place in Hodgkin lymphoma?
    Yahalom J
    Curr Hematol Malig Rep; 2009 Jul; 4(3):117-24. PubMed ID: 20425424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.
    Yahalom J
    Curr Oncol Rep; 2002 Sep; 4(5):415-23. PubMed ID: 12162917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP
    Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced Hodgkin's disease.
    Straus DJ
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):287-302. PubMed ID: 2473061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.
    Yahalom J; Ryu J; Straus DJ; Gaynor JJ; Myers J; Caravelli J; Clarkson BD; Fuks Z
    J Clin Oncol; 1991 Dec; 9(12):2193-201. PubMed ID: 1960560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
    Salvagno L; SorarĂ¹ M; Sotti G; Aversa S; Chiarion Sileni V; Mazzarotto R; Scarzello G; Bianco A; Pappagallo GL; Fiorentino MV
    Ann Oncol; 1995 Feb; 6(2):173-9. PubMed ID: 7540419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
    Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
    J Clin Oncol; 1996 May; 14(5):1421-30. PubMed ID: 8622055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Connors JM; Klimo P; Adams G; Burns BF; Cooper I; Meyer RM; O'Reilly SE; Pater J; Quirt I; Sadura A; Shustik C; Skillings J; Sutcliffe S; Verma S; Yoshida S; Zee B
    J Clin Oncol; 1997 Apr; 15(4):1638-45. PubMed ID: 9193364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
    Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
    J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.